Politics & Government
Newsom Stockpiles 2 Million Abortion Pills Following A Texas Court Decision
Last week, U.S. District Judge Matthew Kacsmaryk granted a motion to "stay" in a case questioning the FDA's approval of Mifepristone.
April 11, 2023
(The Center Square) - A decision by a Texas judge in Alliance for Hippocratic Medicine v. FDA has California Governor Gavin Newsom stockpiling Misoprostol and negotiating to secure up to 2 million more pills.
Find out what's happening in Across Californiafor free with the latest updates from Patch.
Last week, U.S. District Judge Matthew Kacsmaryk granted a motion to “stay” in a case questioning the FDA’s approval of Mifepristone. The Alliance for Hippocratic Medicine filed the petition 21 years ago challenging the legality of the FDA’s approval that was made in 2002.
Mifepristone is a synthetic steroid that blocks the hormone progesterone, halts nutrition, and ultimately starves the unborn human until death. Because mifepristone alone will not always complete the abortion, FDA mandates a two-step drug regimen: mifepristone to kill the unborn human, followed by misoprostol to induce cramping and contractions to expel the unborn human from the mother’s womb.
Find out what's happening in Across Californiafor free with the latest updates from Patch.
“In response to this extremist ban on a medication abortion drug, our state has secured a stockpile of an alternative medication abortion drug to ensure that Californians continue to have access to safe reproductive health treatments. We will not cave to extremists who are trying to outlaw these critical abortion services. Medication abortion remains legal in California.”
So far, the governor has amassed 250,000 Misoprostol pills which induce contractions of the womb. Leaders of California Health & Human Services Agency — including Secretary Dr. Mark Ghaly, California Surgeon General Dr. Diana Ramos, Department of Health Care Services Director Michelle Baass, Department of Managed Health Care Director Mary Watanabe, and Department of Health Care Access and Information Director Elizabeth Landsberg—release the following joint statement:
"California's procurement of misoprostol is not only important in securing access to medication abortion, but to reproductive health care at large for all those who need it. In a time when reproductive justice is under siege across the nation, California continues to ensure access to these rights and strategically find innovative ways to increase access to these services. This procurement is yet another way to ensure that access to reproductive health care is never lacking for Californians.”
Kacsmaryk “stayed” the application of the ruling for a week to allow an appeal to the U.S. Court of Appeals for the 5th Circuit by the administration. The final ruling could have consequences for all states as the legality of Mifepristone’s approval is at stake.
The Reproductive Freedom Alliance which was formed in February and consists of 21 state governors vows to proactively work to protect access in advance of the decision which is expected to be made on Friday.
Newsom budgeted $40 million is to cover provider costs for people who cannot afford care (known as uncompensated care), and $20 million is for an “Abortion Practical Support Fund” to help cover the costs associated with abortion care, including travel and lodging both for people in California and people forced to come to California due to restrictions in their home state in a legislative package of more than $200 million funds specifically targeting reproductive health care.
The focus of the work of The Center Square California is state and local-level government and economic reporting that approaches stories with a taxpayer sensibility.